ICAP Mentor Outlines Importance of Customer Discovery to Drug Developers

Published on :

William McPheat, one of the Life Science Mentors associated with the Innovation Commercialization Assistance Program (ICAP) at George Mason University explained that drug developers need to have an understanding of the future market long before a drug is ever approved by the U.S. Food and Drug Administration. McPheat, who spent more than 25 year with AstraZeneca, said that was something the pharma giant had to explore when planning development programs. And, he said it’s also critical for startups that may be looking to be acquired by a larger company before getting too deep into the clinical process.